An Integrated Global Pharmaceuticals and Life Sciences Company

Investors

Cash Flow (Consolidated)

  • (Rs. Million)
    Particulars For the year ended
    31st March
    2020 2019
    A. Cash flow from operating activities    
    Net profit before tax 12,105.31 9,038.11
    Adjustments:    
    Depreciation, amortisation and impairment expense 4,619.29 3,708.96
    Loss on sale/ disposal/ discard of property, plant and equipment (net) 25.34 46.33
    Finance costs 2,874.09 2,198.08
    Exceptional items 346.37 2,802.30
    Unrealised foreign exchange gain -44.81 -123.75
    Interest income -215.27 -109.68
    Loss on investments at fair value through P&L 2.37 93.09
      7,607.38 8,615.33
    Operating cash flow before working capital changes 19,712.69 17,653.44
    Decrease/ (increase) in trade receivables, loans, other financial assets and other assets 2,197.71 -2,048.18
    (Increase)/ decrease in inventories -3,743.27 166.87
    Decrease in trade payables, other financial liabilities, other liabilities and provisions -251.16 -1,123.96
    Cash generated from operations 17,915.97 14,648.17
    Income tax paid (net of refund) -2,486.59 -3,433.06
    Net cash generated from operating activities 15,429.38 11,215.11
    B. Cash flow from investing activities    
    Purchase of property, plant and equipment, other intangible assets
    (including capital work-in-progress and intangible assets under development)    		 -5,741.53 -6,559.28
    Proceeds from sale of property, plant and equipment 65.32 78.09
    Purchase of investments -36.39 -0.04
    Proceeds from sale of investments 235.75 -
    Payment for acquisition of business (Refer Note 42)   -101.69
    Movement in other bank balances* 1,961.49 -3,623.95
    Interest received 245.33 88.52
    Net cash used in investing activities -3,270.03 -10,118.35
    C. Cash flow arising from financing activities#    
    Proceeds from sale of shares by ESOP Trust/ on exercise of stock options 2.62 2,658.65
    Proceeds from long term borrowings 9,614.67 17,194.14
    Repayment of long term borrowings -16,102.51 -13,126.07
    Payment of lease liabilities -741.67  
    Proceeds from short term borrowings (net) 1,501.76 2,548.12
    Dividend paid (including dividend distribution tax) -1,528.14 -545.86
    Finance costs paid -3,250.43 -2,154.70
    Net cash (used in)/ generated from financing activities -10,503.70 6,574.28
    D. Effect of exchange rate changes 598.52 -58.83
    Net increase in cash and cash equivalents (A+B+C+D) 2,254.17 7,612.21
    Add: cash and cash equivalents at the beginning of year* 10,053.97 2,441.76
    Cash and cash equivalents at the end of the year (Refer note 12 (a))* 12,308.14 10,053.97
  • (Rs. Million)
    Particulars For the year ended
    31st March
    2019 2018

    Cash flow from operating activities

    		 9,038.11 8,590.82
    Net profit before tax    
    Adjustments:    
    Depreciation and amortisation expense 3,708.96 4,150.49
    Loss on sale/ disposal/ discard/ impairment of property, plant and equipment (net) 46.33 41.10
    Finance costs 2,198.08 2,842.83
    Exceptional items 2,802.30 -
    Amortisation of Foreign Currency Monetary Item Translation Difference - (25.25)
    Unrealised foreign exchange loss (including mark-to-market on forward contracts) (123.75) (3.74)
    Interest income (109.68) (51.30)
    Loss / (gain) on investments at fair value through P&L 93.09 (75.88)
    Dividend on investments - (0.14)
      8,615.33 6,878.11
    Operating cash flow before working capital changes 17,653.44 15,468.93
    Increase in trade receivables, loans, other financial assets and other assets (2,048.18) (1,404.10)
    (Increase)/decrease in inventories 166.87 (1,348.78)
    Increase/(decrease) in trade payables, other financial liabilities, other liabilities and provisions (1,123.96) 2,894.35
    Cash generated from operations 14,648.17 15,610.40
    Income tax paid (net of refund) (3,433.06) (2,578.40)
    Net cash generated from operating activities 11,215.11 13,032.00
    Cash flow from investing activities    
    Purchase of property, plant and equipment, other intangible assets (including capital work-in-progress and intangible assets under development) (6,559.28) (4,890.85)
    Proceeds from sale of property, plant and equipment 78.09 53.51
    Purchase of investments (0.04) (195.72)
    Proceeds from sale of investments - 79.45
    Payment for acquisition of business (Refer Note 41) (101.69) (1,305.12)
    Movement in other bank balances* (3,623.95) (9.79)
    Interest received 88.52 91.42
    Dividend received - 0.14
    Net cash used in investing activities (10,118.35) (6,176.96)
    Cash flow arising from financing activities    
    Proceeds from issue of shares by Trust on exercise of stock options 2,658.65 10.23
    Proceeds from long term borrowings 17,194.14 -
    Repayment of long term borrowings** (13,126.07) (6,143.82)
    Proceeds from/(repayment of) short term borrowings (net) 2,548.12 (134.63)
    Dividend paid (including dividend distribution tax) (545.86) (560.30)
    Finance costs paid (2,154.70) (2,182.83)
    Net cash used in financing activities 6,574.28 (9,011.35)
    Effect of exchange rate changes (58.83) 33.63
    Net increase/(decrease) in cash and cash equivalents (A+B+C+D) 7,612.21 (2,122.68)
    Add: cash and cash equivalents at the beginning of year 2,441.76 4,564.44
    Cash and cash equivalents at the end of the year 10,053.97 2,441.76
    * Rs. 2,807.70 million (31 March 2018: Rs. 87.45 million) has restricted use
    ** Revolver facility of Jubilant HollisterStier LLC is presented on net basis.
    # Refer note 16 (c) for changes in liabilities arising from financing activities.
    Note:
    Consolidated Statement of Cash Flows has been prepared under the indirect method as set out in the Ind AS 7 "Statement of Cash Flows".
  • (Rs. Million)
    Particulars For the year ended
    31st March
    2017 2018

    Cash flow from operating activities

    		    
    Net profit before tax 7,376.42 8,590.82
    Adjustments:    
    Depreciation and amortisation expense 2,913.99 4,150.49
    Loss on sale/ disposal/ discard/ impairment of property, plant and equipment (net) 63.44 41.10
    Finance costs 3,411.08 2,842.83
    Employee share-based payment expense 0.01 -
    Amortisation of Foreign Currency Monetary Item Translation Difference 67.15 25.25
    Unrealised foreign exchange loss (including mark-to-market on forward contracts) 12.60 3.74
    Interest income (87.79) (51.30)
    Fixed assets received against termination of customer contract - -
    Dividend on investments (1.47) (75.88)
      6,379.01 6,878.11
    Operating cash flow before working capital changes 13,755.43 15,468.93
    Increase in trade receivables, loans, other financial assets and other assets (835.94) (1,404.10)
    (Increase)/decrease in inventories (328.82) (1,348.78)
    Increase/(decrease) in trade payables, other financial liabilities, other liabilities and provisions 1,533.55 2,894.35
    Cash generated from operations 14,124.22 15,610.40
    Income tax paid (net of refund) (1,439.35) (2,578.40)
    Net cash generated from operating activities 12,684.87 13,032.00
    Cash flow from investing activities    
    Purchase of property, plant and equipment, other intangible assets (including capital work-in-progress and intangible assets under development) (4,641.94) (4,890.85)
    Sale of property, plant and equipment 19.01 53.51
    Purchase of investments (112.33) (195.72)
    Sale of investments 185.89 195.72
    Movement in other bank balances* 11.98 9.79
    Interest received 31.97 91.42
    Dividend received 1.47 0.14
    Net cash used in investing activities (4,503.95) (6,176.96)
    Cash flow arising from financing activities    
    Proceeds from issue of shares by Trust on exercise of stock options 77.37 10.23
    Proceeds from long term borrowings** 21,302.03 -
    Repayment of long term borrowings** (20,453.52) (6,143.82)
    Proceeds from short term borrowings (net of repayments) (4,936.93) 134.63
    Payment to Minority - -
    Receipt of capital subsidy 2.20 -
    Dividend paid (including dividend distribution tax) (558.65) (560.30))
    Finance costs paid (2,291.17) (2,182.83)
    Net cash used in financing activities (6,858.67) (9,011.35)
    Effect of exchange rate changes (150.48) 33.63
    Net increase/(decrease) in cash and cash equivalents (A+B+C+D) 1,171.77 (2,122.68)
    Add: cash and cash equivalents at the beginning of year 3,392.67 4,564.44
    Cash and cash equivalents at the end of the year 4,564.44 2,441.76
    Components of cash and cash equivalents    
    Balances with banks:*    
    - on current accounts 3,805.41 -
    - on dividend accounts 45.57 -
    - on deposits accounts with original maturity up to three months 619.23 -
    Cash on hand 1.73 -
    Cheques/ drafts on hand 2.98 -
    Others    
    - Funds in transit 88.43 -
    - Imprest 1.09 -
      4,564.44 -
  • (Rs. Million)
    Particulars For the year ended
    31st March
    2016 2017

    Cash flow from operating activities

    		    
    Net profit before tax 7,376.42 5,422.23
    Adjustments:    
    Depreciation and amortisation expense 2,913.99 3,467.44
    Loss on sale/ disposal/ discard/ impairment of property, plant and equipment (net) 63.44 89.66
    Finance costs 3,411.08 3,713.52
    Employee share-based payment expense 0.01 5.32
    Amortisation of Foreign Currency Monetary Item Translation Difference 67.15 247.32
    Unrealised foreign exchange loss (including mark-to-market on forward contracts) 12.60 13.26
    Interest income (87.79) (27.39)
    Fixed assets received against termination of customer contract - (130.18)
    Dividend on investments (1.47) -
      6,379.01 7,378.95
    Operating cash flow before working capital changes 13,755.43 12,801.18
    Increase in trade receivables, loans, other financial assets and other assets (835.94) (1,027.61)
    (Increase)/decrease in inventories (328.82) 535.48
    Increase/(decrease) in trade payables, other financial liabilities, other liabilities and provisions 1,533.55 (839.49)
    Cash generated from operations 14,124.22 11,469.56
    Income tax paid (net of refund) (1,439.35) (480.67)
    Net cash generated from operating activities 12,684.87 10,988.89
    Cash flow from investing activities    
    Purchase of property, plant and equipment, other intangible assets (including capital work-in-progress and intangible assets under development) (4,641.94) (3,419.13)
    Sale of property, plant and equipment 19.01 26.77
    Purchase of investments (112.33) (45.05)
    Sale of investments 185.89 302.25
    Movement in other bank balances* 11.98 (19.75)
    Interest received 31.97 29.63
    Dividend received 1.47 -
    Net cash used in investing activities (4,503.95) (3,125.28)
    Cash flow arising from financing activities    
    Proceeds from issue of shares by Trust on exercise of stock options 77.37 196.55
    Proceeds from long term borrowings** 21,302.03 3,826.10
    Repayment of long term borrowings** (20,453.52) (10,240.00)
    Proceeds from short term borrowings (net of repayments) (4,936.93) 1,846.12
    Payment to Minority - (0.27)
    Receipt of capital subsidy 2.20 10.00
    Dividend paid (including dividend distribution tax) (558.65) (555.42)
    Finance costs paid (2,291.17) (3,510.54)
    Net cash used in financing activities (6,858.67) (8,427.46)
    Effect of exchange rate changes (150.48) 40.15
    Net increase/(decrease) in cash and cash equivalents (A+B+C+D) 1,171.77 (523.70)
    Add: cash and cash equivalents at the beginning of year 3,392.67 3,916.37
    Cash and cash equivalents at the end of the year 4,564.44 3,392.67
    Components of cash and cash equivalents    
    Balances with banks:*    
       - on current accounts 3,805.41 3,311.86
       - on dividend accounts 45.57 40.53
       - on deposits accounts with original maturity up to three months 619.23 7.50
    Cash on hand 1.73 2.48
    Cheques/ drafts on hand 2.98 5.58
    Others    
    - Funds in transit 88.43 23.25
    - Imprest 1.09 1.47
      4,564.44 3,392.67
    * 87.26 million (31 March 2016: 84.42 million) has restricted use.
    ** Revolver facility of Jubilant HollisterStier LLC is presented on net basis
  • (Rs. Million)
    Particulars For the year ended
    31st March
    2015

    Cash flow from operating activities

    		  
    Net profit before tax  403.24
    Adjustments :  
    Depreciation and amortisation expense  2,879.54
    Loss on sale/ disposal/ discard/ impairment of fixed assets (net) 429.79
    Finance costs  3,553.40
    Provision for loss on impairment of goodwill  51.25
    Provision for diminution in value of investment  –
    Amortisation of Foreign Currency Monetary Item Translation Difference Account (FCMITDA)  447.52
    Provision for doubtful debts  62.47
    Bad debts/ irrecoverable loans and advances written off (net off provisions written-back)  144.43
    Unrealised foreign exchange (including mark-to-market on currency and interest rate swaps)  (72.96)
    Realised foreign exchange on mark-to-market on currency and interest rate swaps  (167.60)
    Interest income  (62.40)
    Fixed assets received against termination of customer contract  –
    Profit on sale of investment  –
    Dividend on non-trade current investments  (7.01)
       7,258.43
    Operating cash flow before working capital changes  7,661.67
    Increase in trade receivables, loans and advances and other assets  (236.15)
    Decrease in inventories  1,102.65
    (Decrease)/ Increase in trade payables, provisions and other liabilities  97.50
    Cash generated from operations  8,625.67
    Income tax and wealth tax paid (net of refund)  (793.07)
    Net cash generated from operating activities  7,832.60

    Cash flow from investing activities

    		  
    Acquisition/ purchase of fixed assets/ Capital work-in-progress  (3,750.31)
    Sale of fixed assets  258.96
    Purchase of investments  (41.53)
    Sale of investment  –
    Movement in other bank balances*  34.26
    Interest received  58.27
    Dividend received  7.01
    Net cash used in investing activities  (3,433.34)

    Cash flow arising from financing activities

    		  
     Proceeds from long term borrowings**  30,969.42
     Repayment of long term borrowings** (20,412.76)
    Proceeds from short term borrowings (net of repayments)  (6,740.17)
    Net payment on settlement of currency and interest rate swaps  (2,921.85)
    Payment to Minority  (2,030.53)
    Receipt of capital subsidy  –
    Dividend paid (including dividend distribution tax)  (538.05)
    Finance costs paid  (3,352.92)
    Net cash used in financing activities  (5,026.86)

    Effect of exchange rate changes

    		  (190.92)
    Net decrease in cash and cash equivalents (A+B+C+D)  (818.52)
    Add: cash and cash equivalents at the beginning of year  4,734.91
    Adjustment: cash and cash equivalents on deconsolidation of ESOP trust (Refer note 40)  (0.06)
    Cash and cash equivalents at the end of the year  3,916.33
    Components of cash and cash equivalents  
    Balances with banks:*  
    - On current accounts  3,667.20
    - On dividend accounts  34.68
    - On deposits accounts with original maturity up to three months  120.90
    Cash on hand  1.95
    Cheques/Drafts in hand  74.24
    Others  
    - Funds in transit  15.85
    - Imprest  1.51
       3,916.33
    * 84.27 million (Previous year' 83.08 million) has restricted use.
    ** Revolver facility of Jubilant HollisterStier LLC is presented on net basis (Refer note 5.20).       
  • (Rs. Million)
    Particulars For the year ended
    31st March
    2014

    Cash flow arising from operating activities :

    		  
    Net profit before tax 2,072.83
    Adjustments:  
    Depreciation and amortisation expense 2,811.68
    Loss on sale/disposal/discard/impairment of fixed assets (net) 25.11
    Finance costs 3,237.23
    Provision for loss on impairment of goodwill 35.06
    Amortisation of Foreign Currency Monetary Item Translation Difference Account (FCMITDA) 1,000.21
    Provision for doubtful debts 32.96
    Bad debts/irrecoverable loans advances written off (net off provisions written-back) (44.83)
    Unrealised foreign exchange (including mark-to-market on currency and interest rate swaps) 966.69
    Realised foreign exchange on mark-to-market on currency and interest rate swaps (303.20)
    Interest income (52.20)
    Profit on Sale of Business/Investment (142.72)
    Dividend on non-trade current investments -
      7,565.99
    Operating cash flow before working capital changes 9,638.82
    (Increase)/Decrease in trade receivables, loans and advances and other assets 507.37
    Decrease/(increase) in inventories (1,750.04)
    Increase in trade payables, provisions and other liabilities 135.81
    Cash generated from operations 8,531.82
    Income tax and wealth tax paid (net of refund) (809.11)
    Net cash generated from operating activities 7,722.71

    Cash flow from investing activities :

    		  
    Acquisition/purchase of fixed assets/Capital work-in-progress (2,908.08)
    Sale of fixed assets 63.50
    Purchase of investments (62.52)
    Sale of business 407.11
    Movement in other bank balances* 702.83
    Interest received 52.93
    Dividend received -
    Net cash used in investing activities (1,744.23)

    Cash flow arising from financing activities :

    		  
    Proceeds from long term borrowings** 5,163.79
    Repayment of long term borrowings (6,233.20)
    Proceeds from short term borrowings (net of repayments) 516.21
    Net (payment)/ receipt on settlement of currency and interest rate swaps 303.34
    Payment to Minority -
    Receipt of capital subsidy 3.00
    Dividend paid (including dividend distribution tax) (552.36)
    Finance costs paid (3,344.86)
    Net cash used in financing activities (4,144.08)
    Effect of exchange rate changes 114.26
    Net (decrease)/increase in cash and cash equivalents (A+B+C+D) 1,948.66
    Add: cash and cash equivalents at the beginning of year 2,796.47
    Adjustment: cash and cash equivalents on sale of business of Asia Healthcare Development Limited (Refer note 33) (10.28)
    Adjustment: cash and cash equivalents on (deconsolidation)/consolidation of ESOP trust (Refer note40) 0.06
    Cash and cash equivalents at the close of the year 4,734.91
    Components of cash and cash equivalents  
    Balances with banks:*  
    - On current accounts 4,546.12
    On dividend accounts 28.18
    - On deposits accounts with original maturity upto three months 104.95
    Cash on hand 2.29
    Cheques/Drafts in hand 0.23
    Others  
    - Funds in transit 51.43
    - Imprest 1.71
      4,734.91
    * Rs. 83.08 million (Previous year Rs. 198.03 million) has restricted use.
    ** Revolver facility of Jubilant HollisterStier LLC is presented on net basis (Refer note 5.19).
  • (Rs. Million)
    Particulars For the year ended
    31st March
    2013 2012

    Cash flow arising from operating activities :

    		    
    Net profit before tax 3,411 1,141
    Adjustments for:    
    Depreciation & amortisation 2,538 2,207
    Loss/(Gain) on sale/disposal/discard of Fixed Assets/Intangibles 559 209
    Finance costs 2,302 2,096
    Provision for diminution in the value of Investments - 166
    Provision for loss on impairment of goodwill - 1,506
    Amortisation of FCMITDA 632 405
    Provision for doubtful debts 63 23
    Provision for employee benefits 110 122
    Bad debts/irrecoverable advances written off (net off write-in) 13 19
    Unrealised (gain)/loss on exchange
    (including mark-to-market on currency and interest rate swaps)    		 864 1,216
    One time write down of Inventory 108 -
    Income from current investment (non trade) - dividend - (13)
      7,187 7,954
    Operating profit before working capital changes 10,599 9,095
    Adjustments for :    
    (Increase)/Decrease in trade and other receivables (932) (977)
    (Increase)/Decrease in inventories (771) (2,824)
    Increase/(Decrease) in trade and other payables 1,999 2,432
    Cash generated from operations 10,895 7,726
    Direct taxes paid (net of refunds) (1,196) (655)
    Net cash inflow/(outflow) in course of operating activities 9,700 7,072

    Cash flow arising from investing activities :

    		    
    Acquisition/purchase of fixed assets/CWIP
    (including capital advances)    		 (4,641) (6,146)
    Sale proceeds of fixed assets 264 13
    (Purchase)/sale of investments (net) (54) (10)
    Payment for acquisition of subsidiaries - (42)
    Movement in other bank balances (728) 6
    Interest received 161 222
    Dividend received - 13
    Net cash inflow/(outflow) in course of investing activities (4,998) (5,943)

    Cash flow arising from financing activities :

    		    
    Proceeds from long term & short term borrowings 5,578 9,181
    Repayment of long term & short term borrowings (7,144) (6,097)
    Repayment of FCCB(including premium on redemption of FCCB) - (9,442)
    Dividend paid (including dividend distribution tax) (548) (368)
    Finance cost paid (2,384) (2,163)
    Net cash inflow/(outflow) in course of financing activities (4,4978) (8,888)
    Foreign currency translation difference arising on consolidation (38) (41)
    Net increase in cash & cash equivalents (A+B+C+D) 166 (7,800)
    Add: cash & cash equivalents at the beginning of year (including balance in dividend accounts) 2,631 10,412
    Add: cash & cash equivalents on consolidation of subsidiaries acquired during the year - 20
    Adjustment: cash & cash equivalents on account of scheme of amalgamation & demerger - -
    Cash & cash equivalents at the close of the year (including balance in dividend accounts) 2,796 2,631
  • (Rs. Million)
    Particulars For the year ended
    31st March
    2011 2010 2009 2008 2007

    Cash Flow Summary

    		          
    Cash and Cash Equivalents at Beginning of the year 5,037 3,817 5,238 8,749 1,390
    Net Cash from Operating Activities 3,880 7,096 4,570 2,575 1,906
    Net Cash Used in Investing Activities (3,531) (2,797) (20,307) (11,393) (3,675)
    Net Cash Used in Financing Activities 6,101 (2,980) 12,517 5,928 9,629
    Change in Foreign Currency Translation Reserve on Consolidation 474 (84) 1,342 (622) (-501)
    Net Inc/(Dec) in Cash and Cash Equivalent  6,924 1,234 (1,878) (3,513) 7,360
    Unrealized Exchange Difference on Foreign Currency Cash and Cash Equivalents 0.9 (18) 58 (0.5) (0.2)
    Cash and Cash Equivalents on Consolidation of new subsidiaries (1,503) 3 400 2 -
    Cash and Cash Equivalents at End of the year 10,457 5,037 3,817 5,238 8,750

 

Investors